483
Chiesi Farmaceutici S.p.A.FDA 483 - Chiesi Farmaceutici S.p.A. - March 28, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Chiesi Farmaceutici S.p.A. in Parma, Italy, revealed significant deficiencies in quality control. Observations included inadequate visual inspection procedures and operator qualification, insufficient acceptance criteria for biological indicators in sterilization, and compromised drug product system integrity due to observed droplets. These issues collectively point to a heightened risk of product quality and sterility concerns.
Open in Dashboard
ID · e5aac9bd-5951-4844-b819-6e4761d9a295